glp-1 and substance use disorder medications get at the heart of addiction, study finds GLP-1 drugs linked to lower

Mechanism: Why these drugs work (and why they cause problems) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were initially approved in 2005 for the treatment of type 2 diabetes

Exenatide (Ex-4) and liraglutide are effective in modulating key pathways involved in neurodegeneration, such as apoptosis, mitochondrial function, and autophagy, in models of AD and PD

Retatrutide, with triple-target effects (it works at the two receptors mentioned above and the glucagon receptor), caused people to lose about a quarter of their body weight after a year in a Phase II study (Jastreboff AM et al, N Engl J Med 2023;389(6):514526), although a follow-up study found the weight loss more in line with tirzepatide

This variety pack contains roasted fava beans and chickpeas

You should not stop your medication due to tiredness without first talking to your healthcare provider

Beyond their role in digestion, bile acids also function as signaling molecules that regulate metabolic processes, including the secretion of incretin hormones such as GLP-1